Loading chat...
DE HB356
Bill
Status
10/14/2022
Primary Sponsor
Sherry Dorsey Walker
Click for details
AI Summary
-
Terminates the Medical Marijuana Act Oversight Committee, a 9-member body established to evaluate and make recommendations regarding the state's medical marijuana program
-
Transfers authority for approving cannabidiol-rich (CBD-rich) marijuana strain profiles and medical marijuana oil formulation changes solely to the Department of Health and Social Services, removing the Oversight Committee's advisory role
-
Follows a review by the Joint Legislative Oversight and Sunset Committee (JLOSC), which found the Oversight Committee made only 2 recommendations to the Office of Medical Marijuana since October 15, 2015, and no recommendations to the Governor or General Assembly
-
The Office of Medical Marijuana will continue operating the medical marijuana program without the Committee's support, as JLOSC determined the Committee is not meeting a public need
Legislative Description
An Act To Amend Title 16 Of The Delaware Code Relating To The Delaware Medical Marijuana Act.
Last Action
Signed by Governor
10/14/2022